TRACE

STUDY IDENTIFIER:

TRACE

CONDITION:

Peripheral artery disease

CONTACT INFO:

Stephanie Ebnet   |   stephanie.ebnet@allina.com   |   612-863-6286

DESCRIPTION:

The purpose of this study is to determine if a FDA approved drug called Vorapaxar (Zontivity) indicated for use along with Aspirin and/or Plavix as prescribed by your doctor, can improve symptoms of intermittent claudication.

CRITERIA LIST/ QUALIFICATIONS:

Peripheral artery disease

INVESTIGATORS:

Nedaa Skeik, M.D.

SPONSORS:

VA North Texas Health Care System

STATUS:

Open/Enrolling

Support the research and educational efforts of MHIF

Make a Donation